TipRanks
Go Ultimate55% OFF
PC:AUREK

Aureka Biotechnologies: Valuation, Funding & Investors

Aureka Biotechnologies develops biological foundation models to accelerate drug discovery and development. The company focuses on de novo molecular design, biological structure modeling, and function prediction, integrating models with its Lab-in-the-Loop feedback engine, single-cell functional screening, high-throughput experimental validation, and drug development platforms.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$100M
Total Funding Rounds
1
Latest Funding Amount
$100M
Latest Funding Round
Series B

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Aug 11, 2026Series B$100.00M―

Investors

Investor NameFunding Round
Granite AsiaSeries B
Prominent strategic investorSeries B
MPCiSeries B
NRL CapitalSeries B

Similar Companies

A snapshot of private companies similar to Aureka Biotechnologies, helping you discover and navigate related company profiles.

Related News and Analysis